Development of Novel Drug Delivery Systems for Enhanced Therapeutic Efficacy in Cancer Treatment

Thesis Abstract

Abstract
Cancer remains one of the leading causes of mortality worldwide, necessitating the continuous exploration of innovative therapeutic strategies. The development of novel drug delivery systems has emerged as a promising approach to enhance the efficacy of cancer treatment while minimizing adverse effects on healthy tissues. This thesis focuses on the design and evaluation of advanced drug delivery systems for targeted delivery of anticancer agents. The introduction provides a comprehensive overview of the current challenges in cancer treatment, emphasizing the limitations of conventional chemotherapy and the potential benefits of novel drug delivery systems. The background of the study explores the underlying principles of drug delivery, highlighting the importance of optimizing drug formulations for enhanced therapeutic outcomes. The problem statement identifies the gaps in existing cancer treatment modalities and underscores the need for novel drug delivery systems to address these limitations. The objectives of the study are outlined to guide the research process towards developing efficacious and safe drug delivery platforms for cancer therapy. The research methodology section delineates the experimental approach, including the selection of drug candidates, formulation design, in vitro and in vivo evaluation methods, and data analysis techniques. The discussion of findings chapter presents a detailed analysis of the results obtained from the characterization and evaluation of the novel drug delivery systems, highlighting their efficacy in targeting cancer cells and reducing off-target effects. The conclusion and summary chapter provide a comprehensive overview of the key findings and implications of the study, emphasizing the significance of the developed drug delivery systems in improving the efficacy and safety of cancer treatment. The thesis contributes to the growing body of knowledge in the field of cancer drug delivery and sets the stage for further research and development in this critical area of oncology. In conclusion, the development of novel drug delivery systems holds great promise for enhancing the therapeutic efficacy of cancer treatment. By targeting specific cancer cells and minimizing systemic toxicity, these advanced drug delivery platforms have the potential to revolutionize the field of oncology and improve patient outcomes. Further research and clinical trials are warranted to validate the efficacy and safety of these innovative drug delivery systems in real-world clinical settings.